mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.05 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.05 |
mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.05 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.06 |
mRNA |
NSC23766 |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.06 |
mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.06 |
mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.06 |
mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.06 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.06 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.07 |